{"id":871057,"date":"2025-08-05T13:49:09","date_gmt":"2025-08-05T17:49:09","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/"},"modified":"2025-08-05T13:49:09","modified_gmt":"2025-08-05T17:49:09","slug":"brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/","title":{"rendered":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BALA CYNWYD, Pa., Aug.  05, 2025  (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kDvihP-RyXQAlDqB7xYdcmpags-IIbft9ZK2JYU7ywdajayKol_zLJii0ezGw4OCakQic8Dibts1-60CRyQGlQKUlj6fsa4HSi-lFlRY8jRcnun5GwcAa8IIxbAo7mwu\" rel=\"nofollow\" target=\"_blank\">jbrodsky@brodskysmith.com<\/a>) or Marc Ackerman (<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3MuD-dVXqSsWfOXZJ0tGBXlu5YQBinO0Jv9FUT_bPTUlynOAUOBA9UaaIXOVCTKAbVistlaDOn3ZBKm9Obx6S9K8soOcCXaGfIIgnmMjjB8HqYka3dgXJNNQuwnUkbHK\" rel=\"nofollow\" target=\"_blank\">mackerman@brodskysmith.com<\/a>) at 855-576-4847. There is no cost or financial obligation to you.<\/p>\n<p>\n        <strong>STAAR Surgical Company (Nasdaq \u2013 STAA)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, STARR will be acquired by Alcon (NYSE &#8211; ALC) for $28.00 in cash for each share of STAAR they own. The transaction represents a total equity value of approximately $1.5 billion. The investigation concerns whether the STAAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2CFF5hCl3W_w7N3gv-exLVlBOOHCBTNrihz7RLomfoh-7L07p2aiWhKft59FVd5pT2hy1_MPN0EnfwJNhqa0japMiUW13blEKyMXDy_320YR0cTYgf-WemvHPkDMGFKHGaKO9yvo8paFnr-wawu_KjOMESG9Ck4dqj-7y9mYdurHxO9ka_wqxbkl-lTEzCLY26S4btS89R0Sv6ErUsfVIA_ua11OmsK7lf6YO4J4TYA=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/staar-surgical-company-nasdaq-staa\/<\/a>.<\/p>\n<p>\n        <strong>Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Y-mAbs will be acquired by SERB Pharmaceuticals (\u201cSERB\u201d) for $8.60 in cash for each share of Y-mAbs they own. The transaction represents a total equity value of approximately $412 million. The investigation concerns whether the Y-mAbs Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company\u2019s shareholders.<\/p>\n<p>Additional information can be found at<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2CFF5hCl3W_w7N3gv-exLVlBOOHCBTNrihz7RLomfoivLUA-NBHkmqZs0kyvaedMnr4DeN6MgeCIA_qwloajlRhjodupTVOoWSCNWTek_Vr1Y_mrJi3-NRQgepOYr0Lv3B5WQHJSZ8giZ4kPeesTX4YNR2JyccqQUzkYeg3uzAR--0kqDQ3INLKZPifHF9UgFcWbO6RnMrlY3WMvdFo9CQCMLtrkZQdQzkLneJW3FK4=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/y-mabs-therapeutics-inc-nasdaq-ymab\/<\/a>.<\/p>\n<p>\n        <strong>Core Scientific, Inc. (Nasdaq &#8211; CORZ)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the Merger Agreement, Core Scientific will be acquired by CoreWeave (Nasdaq &#8211; CRWV). Core Scientific stockholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock based on a fixed exchange ratio. As of July 3, 2025, the agreed-upon exchange ratio implies a total equity value of approximately $9.0 billion. The investigation concerns whether the Core Scientific Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company\u2019s shareholders.<\/p>\n<p>Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2CFF5hCl3W_w7N3gv-exLVlBOOHCBTNrihz7RLomfojxVam7XFufI6xN4Mazhn9NsYpUyjCHIGpS_HbgZEQ5TOeO4OHpJ2jIdv3TJoxcPrgiTqRMxNWnjV1aMaU5z5vtbLNMJExeyNWWMfdlkhpVLTQsZhuW0NOsLnYItcK36I_HHfB2pIF3iwwL2BRlnISNSbr2GFaOnMqRSI98g8HDStXzFOBA_S4buvWPvRmhwYk=\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/core-scientific-inc-nasdaq-corz\/<\/a>.<\/p>\n<p>\n        <strong>Couchbase, Inc. (Nasdaq \u2013 BASE)<\/strong>\n      <\/p>\n<p align=\"justify\">Under the terms of the agreement, Couchbase will be acquired by Haveli Investments. Inc. for $24.50 in cash for each Couchbase share. The investigation concerns whether the Couchbase Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal consideration provides fair value to the Company\u2019s shareholders.<\/p>\n<p align=\"justify\">Additional information can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2CFF5hCl3W_w7N3gv-exLVlBOOHCBTNrihz7RLomfojxVam7XFufI6xN4Mazhn9NEpsDhmdsHf3c5mZZfW0MXMFuTIVTzrJnmXSr40CIr3xD-oy6prIOq3fMx26SA-kEOembDiwSAQWI2q4JeQw2y2RhntQDWwC-MQbY_0bRfyyhhSLnrkhn9MLBi7AGc-O2kLxCRHJhfVctoTsD2tMUNA==\" rel=\"nofollow\" target=\"_blank\">https:\/\/www.brodskysmith.com\/cases\/couchbase-inc-nasdaq-base\/<\/a>.<\/p>\n<p align=\"justify\">Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODM1MzM3ZDctZTA0Yy00MzAzLTg2MjUtM2QxNTY1OTAxNTNiLTExOTk4MzEtMjAyNS0wOC0wNS1lbg==\/tiny\/Brodsky-Smith-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BALA CYNWYD, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. STAAR Surgical Company (Nasdaq \u2013 STAA) Under the terms of the Merger Agreement, STARR will be acquired by Alcon (NYSE &#8211; ALC) for $28.00 in cash for each share of STAAR they own. The transaction represents a total equity value of approximately $1.5 billion. The investigation concerns whether the STAAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-871057","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BALA CYNWYD, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. STAAR Surgical Company (Nasdaq \u2013 STAA) Under the terms of the Merger Agreement, STARR will be acquired by Alcon (NYSE &#8211; ALC) for $28.00 in cash for each share of STAAR they own. The transaction represents a total equity value of approximately $1.5 billion. The investigation concerns whether the STAAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the &hellip; Continue reading &quot;BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-05T17:49:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)\",\"datePublished\":\"2025-08-05T17:49:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/\"},\"wordCount\":497,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/\",\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\",\"datePublished\":\"2025-08-05T17:49:09+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/","og_locale":"en_US","og_type":"article","og_title":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk","og_description":"BALA CYNWYD, Pa., Aug. 05, 2025 (GLOBE NEWSWIRE) &#8212; Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you. STAAR Surgical Company (Nasdaq \u2013 STAA) Under the terms of the Merger Agreement, STARR will be acquired by Alcon (NYSE &#8211; ALC) for $28.00 in cash for each share of STAAR they own. The transaction represents a total equity value of approximately $1.5 billion. The investigation concerns whether the STAAR Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the &hellip; Continue reading \"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-05T17:49:09+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)","datePublished":"2025-08-05T17:49:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/"},"wordCount":497,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/","name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq - CORZ) - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=","datePublished":"2025-08-05T17:49:09+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUwNjUzOSM3MDgyODkyIzIxODgyNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/brodsky-smith-shareholder-update-notifying-investors-of-the-following-investigations-staar-surgical-company-nasdaq-staa-y-mabs-therapeutics-inc-nasdaq-ymab-couchbas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BRODSKY &amp; SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: STAAR Surgical Company (Nasdaq \u2013 STAA), Y-mAbs Therapeutics, Inc. (Nasdaq \u2013 YMAB), Couchbase, Inc. (Nasdaq \u2013 BASE), Core Scientific, Inc. (Nasdaq &#8211; CORZ)"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=871057"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/871057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=871057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=871057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=871057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}